Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Teleflex Inc (NY: TFX )

239.94 +5.80 (+2.48%)
Official Closing Price Updated: 7:00 PM EDT, Oct 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 432,093
Open 235.77
Bid (Size) 234.51 (1)
Ask (Size) 244.93 (1)
Prev. Close 234.14
Today's Range 234.43 - 241.41
52wk Range 177.63 - 257.85
Shares Outstanding 46,801,138
Dividend Yield 0.57%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
New Data Presented at ASTRO 2024 Further Demonstrate the Safety and Efficacy of Barrigel™ Rectal Spacer, the First and Only Sculptable Hyaluronic Acid Rectal Spacer, in Patients Undergoing Radiation Therapy for Prostate Cancer(1-3)
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Announces Third Quarter 2024 Earnings Conference Call Information
From Teleflex Incorporated
Via GlobeNewswire

Performance

YTD
-4.19%
-4.19%
1 Month
-0.66%
-0.66%
3 Month
+8.18%
+8.18%
6 Month
+16.16%
+16.16%
1 Year
+28.99%
+28.99%

More News

Read More
Where Teleflex Stands With Analysts
Via Benzinga
(TFX) - Analyzing Teleflex's Short Interest
Via Benzinga
How Is The Market Feeling About Teleflex?
Via Benzinga
Beyond The Numbers: 5 Analysts Discuss Teleflex Stock
Via Benzinga
A Glimpse Into The Expert Outlook On Teleflex Through 4 Analysts
Via Benzinga
(TFX) - Analyzing Teleflex's Short Interest
Via Benzinga
Teleflex’s Barrigel Rectal Spacer to Be Featured in Three Presentations at the 2024 American Society for Radiation Oncology (ASTRO) Annual Meeting
From Teleflex Incorporated
Via GlobeNewswire
Teleflex™ Chooses o9’s AI-Powered Platform for End-to-End Integrated Business Planning and Supply Chain Management
From o9
Via Business Wire
Peering Into Teleflex's Recent Short Interest
Via Benzinga
Expert Ratings For Teleflex
Via Benzinga
Teleflex to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Announces Publication of a Propensity Matching Review of Retrospective Data Reporting that the Titan SGS™ Stapler Enables Consistent Gastric Pouch Formation with Fewer Variations, Providing Potentially Enhanced Clinical Outcomes and Significant
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Announces Quarterly Dividend
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Reports Second Quarter Financial Results and Full Year 2024 Outlook
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Expands Interventional Cardiology Portfolio with FDA 510(k) Clearance of the Ringer™ Perfusion Balloon Catheter
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Awarded Hemostasis Products Agreements with Premier, Inc.
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Announces the Teleflex Center for Antimicrobial Protection
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Announces Second Quarter 2024 Earnings Conference Call Information
From Teleflex Incorporated
Via GlobeNewswire
This Medical Devices Stock Has Several Catalysts, Says Bullish Analyst
Via Benzinga
Teleflex Publishes 2023 Global Impact Report
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Expands Intraosseous Vascular Access Portfolio with New Arrow™ EZ-IO™ Intraosseous Access Procedure Tray
From Teleflex Incorporated
Via GlobeNewswire
Outcomes From Two New Head-to-Head Randomized Controlled Trials Involving the UroLift™ System Highlight a Superior Patient Experience* Against Rezūm and Its Advantage Over Medical Therapy as an Early Intervention for BPH
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Announces Quarterly Dividend
From Teleflex Incorporated
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.